Barclays analyst Andrew Mok raised the firm’s price target on Addus HomeCare (ADUS) to $117 from $111 and keeps an Underweight rating on the shares following the Q3 report. The firm says that despite a 2% revenue beat, Addus’ adjusted EBITDA finished only 1.6% ahead of Street estimates driven by higher cost of services.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADUS: